Protein detail

ITA6

Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]

Entry name
ITA6
UniProt ID
EVMP confidence score
0.25
Supporting publications (n)
1
Transmembrane count
1
Protein classification
Cancer-related genesCD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)]
Protein Class (9)
Cancer-related genesCD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function (8)
  • Cancer-related genes:Mutational cancer driver genes
  • Predicted intracellular proteins
  • CD markers
  • Potential drug targets
  • Cancer-related genes:Candidate cancer biomarkers
  • Human disease related genes:Congenital malformations:Congenital malformations of skin
  • Transporters:Accessory Factors Involved in Transport
  • Disease related genes
Transmembrane
1051..1076; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
CD49f
Gene Description
Integrin subunit alpha 6
Chromosome
2
Position
172427354-172506459
Supporting publications (n)
1
EVMP confidence score
0.25
Fluorescence & Localization3
Cell SpecificAstrocytesSingle-Nuclei Brain Specificcommitted oligodendrocyte precursorBlood Cell Specificneutrophil
Function & Pathway7
Protein Function (8)
  • Cancer-related genes:Mutational cancer driver genes
  • Predicted intracellular proteins
  • CD markers
  • Potential drug targets
  • Cancer-related genes:Candidate cancer biomarkers
  • Human disease related genes:Congenital malformations:Congenital malformations of skin
  • Transporters:Accessory Factors Involved in Transport
  • Disease related genes
Mediation Categories (4)
Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence65

Ligand-Receptor Signaling (63)

63 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPINoNoNoYesNo
intracellularintracellularOmniPathNoNoNoYesNo
adhesionadhesionAdhesomeYesYesNoYesNo
cell_adhesioncell_adhesionCellinkerYesYesNoYesNo
integrincell_adhesionOmniPathYesYesNoYesNo
matrix_adhesionmatrix_adhesionCellinkerNoYesNoYesNo
integrinmatrix_adhesionIntegrinsNoYesNoYesNo
integrinmatrix_adhesionUniProt_keywordNoYesNoYesNo
matrix_adhesionmatrix_adhesionZhong2015NoYesNoYesNo
integrinmatrix_adhesionAlmen2009NoYesNoYesNo
Page 3 of 7PreviousNext

Regulatory Interaction Network (1)

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
ITA6P23229PMP22Q01453YesYesNoSIGNORSIGNOR:16436605

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry138008423
Sequence, Structure & Domains14

Sequences

Length
1,130
Mass
126,606
Sequence
MAAAGQLCLLYLSAGLLSRLGAAFNLDTREDNVIRKYGDPGSLFGFSLAMHWQLQPEDKRLLLVGAPRAEALPLQRANRTGGLYSCDITARGPCTRIEFDNDADPTSESKEDQWMGVTVQSQGPGGKVVTCAHRYEKRQHVNTKQESRDIFGRCYVLSQNLRIEDDMDGGDWSFCDGRLRGHEKFGSCQQGVAATFTKDFHYIVFGAPGTYNWKGIVRVEQKNNTFFDMNIFEDGPYEVGGETEHDESLVPVPANSYLGLLFLTSVSYTDPDQFVYKTRPPREQPDTFPDVMMNSYLGFSLDSGKGIVSKDEITFVSGAPRANHSGAVVLLKRDMKSAHLLPEHIFDGEGLASSFGYDVAVVDLNKDGWQDIVIGAPQYFDRDGEVGGAVYVYMNQQGRWNNVKPIRLNGTKDSMFGIAVKNIGDINQDGYPDIAVGAPYDDLGKVFIYHGSANGINTKPTQVLKGISPYFGYSIAGNMDLDRNSYPDVAVGSLSDSVTIFRSRPVINIQKTITVTPNRIDLRQKTACGAPSGICLQVKSCFEYTANPAGYNPSISIVGTLEAEKERRKSGLSSRVQFRNQGSEPKYTQELTLKRQKQKVCMEETLWLQDNIRDKLRPIPITASVEIQEPSSRRRVNSLPEVLPILNSDEPKTAHIDVHFLKEGCGDDNVCNSNLKLEYKFCTREGNQDKFSYLPIQKGVPELVLKDQKDIALEITVTNSPSNPRNPTKDGDDAHEAKLIATFPDTLTYSAYRELRAFPEKQLSCVANQNGSQADCELGNPFKRNSNVTFYLVLSTTEVTFDTPDLDINLKLETTSNQDNLAPITAKAKVVIELLLSVSGVAKPSQVYFGGTVVGEQAMKSEDEVGSLIEYEFRVINLGKPLTNLGTATLNIQWPKEISNGKWLLYLVKVESKGLEKVTCEPQKEINSLNLTESHNSRKKREITEKQIDDNRKFSLFAERKYQTLNCSVNVNCVNIRCPLRGLDSKASLILRSRLWNSTFLEEYSKLNYLDILMRAFIDVTAAAENIRLPNAGTQVRVTVFPSKTVAQYSGVPWWIILVAILAGILMLALLVFILWKCGFFKRSRYDDSVPRYHAVRIRKEEREIKDEKYIDNLEKKQWITKWNENESYS
Alternative Products
Event=Alternative splicing; Named isoforms=8; Comment=Additional isoforms seem to exist. There is a combination of at least four alternatively spliced domains, two extracellular (X1 and X2) and two cytoplasmic (A and B). So far detected are isoform Alpha-6X1A, isoform Alpha-6X1B and isoform Alpha-6X1X2A (minor). Experimental confirmation may be lacking for some isoforms.; Name=Alpha-6X1X2B; IsoId=P23229-1; Sequence=Displayed; Name=Alpha-6X1A; IsoId=P23229-2; Sequence=VSP_002724, VSP_002725; Name=Alpha-6X1B; IsoId=P23229-3; Sequence=VSP_002724; Name=Alpha-6X2A; IsoId=P23229-4; Sequence=VSP_002723, VSP_002725; Name=Alpha-6X2B; IsoId=P23229-5; Sequence=VSP_002723; Name=Alpha-6X1X2A; IsoId=P23229-6; Sequence=VSP_002725; Name=7; IsoId=P23229-7; Sequence=VSP_036406, VSP_002723, VSP_002725; Name=9; IsoId=P23229-9; Sequence=VSP_036407, VSP_002725
Alternative Sequence
1..114; Missing (in isoform 7); 215..258; Missing (in isoform Alpha-6X2A, isoform Alpha-6X2B and isoform 7); 259..297; Missing (in isoform Alpha-6X1A and isoform Alpha-6X1B); 918..932; Missing (in isoform 9); 1084..1130; SRYDDSVPRYHAVRIRKEEREIKDEKYIDNLEKKQWITKWNENESYS -> NKKDHYDATYHKAEIHAQPSDKERLTSDA (in isoform Alpha-6X1A, isoform Alpha-6X2A, isoform Alpha-6X1X2A, isoform 7 and isoform 9)

3D Structural Models

Turn
30..32; 105..107; 174..177; 182..187
Helix
210..213; 322..324
Beta Strand
34..37; 46..53; 59..66; 75..79; 81..87; 115..121; 128..132; 136..140; 147..149; 153..157; 159..162; 165..170; 192..196; 203..207; 215..220; 299..319; 326..333; 335..347; 357..362; 367..369; 371..376; 389..393; 406..409; 420..424; 429..431; 433..438; 445..452; 455..465; 467..479; 481..486; 488..501; 506..517; 527..529; 535..550; 557..563; 587..590; 600..607; 619..624; 652..660
3D Structure
Electron microscopy (1); X-ray crystallography (1)

Domain & Motif Annotations

Repeat
30..95; FG-GAP 1; 101..166; FG-GAP 2; 176..229; FG-GAP 3; 283..339; FG-GAP 4; 340..402; FG-GAP 5; 403..458; FG-GAP 6; 459..518; FG-GAP 7
Motif
1079..1083; GFFKR motif
Region
1077..1083; Interaction with HPS5
Protein Families
Integrin alpha chain family
Sequence Similarities
Belongs to the integrin alpha chain family.
Clinical Relevance5
Disease Involvement (2)
Cancer-related genesEpidermolysis bullosa
Interaction Protein (2)
ENSG00000150093ENSG00000177697
Interaction Count
2
Interaction Dataset (2)
intact_biogridintact_biogrid_opencell
Supporting Publications1
PMIDTitleAbstract
34889606Surface Nanosieving Polyether Sulfone Particles with Graphene Oxide Encapsulation for the Negative Isolation toward Extracellular Vesicles.No abstract available